Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.
about
Understanding of molecular mechanisms in natural killer cell therapyNK cells in therapy of cancerTOX2 regulates human natural killer cell development by controlling T-BET expressionEarly chimerism threshold predicts sustained engraftment and NK-cell tolerance in prenatal allogeneic chimeras.Human natural killer cell development in secondary lymphoid tissuesKiller Ig-like receptor (KIR) genotype predicts the capacity of human KIR-positive CD56dim NK cells to respond to pathogen-associated signals.Immunotherapy for pediatric cancer.CD34+ hematopoietic precursors are present in human decidua and differentiate into natural killer cells upon interaction with stromal cells.Natural killer-cell differentiation by myeloid progenitorsImmunological considerations in in utero hematopoetic stem cell transplantation (IUHCT)Development of IL-22-producing NK lineage cells from umbilical cord blood hematopoietic stem cells in the absence of secondary lymphoid tissueNK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions.Natural killer cell differentiation from hematopoietic stem cells: a comparative analysis of heparin- and stromal cell-supported methodsTim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity.Generation of CD2(+)CD8(+) NK Cells from c-kit(+) Bone Marrow Cells in Porcine'Emergency exit' of bone-marrow-resident CD34(+)DNAM-1(bright)CXCR4(+)-committed lymphoid precursors during chronic infection and inflammationA Reproducible Method for Isolation and In Vitro Culture of Functional Human Lymphoid Stromal Cells from TonsilsDonor major histocompatibility complex class I expression determines the outcome of prenatal transplantation.NKp80 Defines a Critical Step during Human Natural Killer Cell Development.Immature NK cells, capable of producing IL-22, are present in human uterine mucosaHuman embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity.FCRL6 distinguishes mature cytotoxic lymphocytes and is upregulated in patients with B-cell chronic lymphocytic leukemiaLocation and cellular stages of natural killer cell development.Toward clinical therapies using hematopoietic cells derived from human pluripotent stem cells.Genetic and environmental determinants of human NK cell diversity revealed by mass cytometryThe biology of NK cells and their receptors affects clinical outcomes after hematopoietic cell transplantation (HCT).The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cellsNatural killer cells: tolerance to self and innate immunity to viral infection and malignancy.In vivo generation of decidual natural killer cells from resident hematopoietic progenitors.Natural Killer Cell Development and Maturation Revisited: Possible Implications of a Novel Distinct Lin-CD34+DNAM-1brightCXCR4+ Cell Progenitor.Modeling Human Natural Killer Cell Development in the Era of Innate Lymphoid Cells.Roles and mechanism of natural killer cells in clinical and experimental transplantation.Generation of natural killer cells from hematopoietic stem cells in vitro for immunotherapyAt the Bench: Preclinical rationale for exploiting NK cells and γδ T lymphocytes for the treatment of high-risk leukemias.Natural killer cells and regulatory T cells: how to manipulate a graft for optimal GVL.Clinical utility of natural killer cells in cancer therapy and transplantation.Deferasirox nephrotoxicity-the knowns and unknowns.Cysteine cathepsins as regulators of the cytotoxicity of NK and T cells.Expression of chimeric receptor CD4ζ by natural killer cells derived from human pluripotent stem cells improves in vitro activity but does not enhance suppression of HIV infection in vivo.NK cell tolerance as the final endorsement of prenatal tolerance after in utero hematopoietic cellular transplantation.
P2860
Q28086976-C51EA21B-41FC-4A55-BA55-49E0FAC3E325Q28242241-6755172B-7174-4F47-9CA6-5F4D9CBF7DBBQ28854590-B61689FA-7833-4B8F-8E7E-9B1C724238AEQ30437635-7D61DB62-9613-4F5C-9860-98BB61E162ECQ33567199-A4817368-1207-4313-9D0A-20DA23C93F9EQ33789537-C83B403C-A9B8-4B51-B69A-4E280B96D3F1Q33924586-A8EC2D00-4AB6-4B7F-9E62-67B3E2C31F25Q34572976-B3937F99-8A93-494B-9D25-4E9B53915EC3Q34773999-D1CA23FC-A68D-42C6-B249-7EF6384C1F1BQ34839054-89F23C8F-87F0-4A60-92CE-A384ADD1656CQ34924388-44A79DA9-3F87-4950-931D-251E07CA5A80Q35212365-442532E7-200B-4429-A498-02245BE3DBA8Q35830835-35D5E5A2-DD4B-45A0-939D-55CDE6A5017FQ35909663-DA2ADA5A-C04C-4917-A532-B76A14EC487BQ36089776-AE6B7FE3-7384-4513-BBF8-BB2922CC06FDQ36145878-ED7D9000-B288-4120-A7B0-9BCA6F690FF4Q36210450-E35039DD-3DEA-4368-8545-CBC59816530DQ36983165-37ABFDE5-7D04-4010-B3E6-FFBEC40D9D1EQ37145726-FBDA2397-1F0B-459C-8567-684FD54016F5Q37226619-4C9333C1-1A28-4335-B8BD-AD5CE14D9062Q37234607-31A971F1-B1D6-4DF7-A9D1-9DD3AA0F2208Q37343462-606178EF-6D9A-4352-8439-C674E0954713Q37366117-D5161DC6-446F-418D-8178-16CB0775C09FQ37398305-16B09B4B-B3EB-4407-9DB4-181128C6FBDDQ37569278-1F9BCEA4-E910-424E-AA2D-A23EB6A02CDFQ37589671-F4DB7602-F9B4-43FD-BDB0-6348CC264EB5Q37606560-3C6ECA6D-A4DC-400E-8BB3-5E7DC8F84954Q37616324-B457761F-DF50-4CFB-A67D-503D8AD1AC9DQ37618891-F39CE489-910B-4CB5-94EF-23DD47CF8C79Q37689426-BEB3B70E-DBD5-45D6-8BF0-011E32FA9B4BQ37721588-5457B5AF-CAC1-441C-BEC3-83639257710BQ37755212-A5080A52-7837-4811-A08B-AEBB4BF0E9D6Q38019320-A7BA3634-8C73-4261-95F0-7EFFF8A39A6BQ38151057-2BB126A7-2719-48C0-9232-0E571EB2FF9AQ38169654-524FC861-CBD7-45B1-B899-CCCF28066335Q38195120-2C1C8DD8-A5FC-4A73-8FEA-13EA5AF6985BQ38232442-56772270-2A6A-4DE4-B105-9AEF33EE3B78Q38292676-74C51F32-F252-4098-AF65-94A0CD0EB11DQ38365989-8245B3D6-1E70-4933-83A0-AFF7C27D2235Q38410880-3CC8FC27-8DAD-4EB9-8181-EA6F81BF3F0C
P2860
Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Coordinated acquisition of inh ...... ng human natural killer cells.
@ast
Coordinated acquisition of inh ...... ng human natural killer cells.
@en
type
label
Coordinated acquisition of inh ...... ng human natural killer cells.
@ast
Coordinated acquisition of inh ...... ng human natural killer cells.
@en
prefLabel
Coordinated acquisition of inh ...... ng human natural killer cells.
@ast
Coordinated acquisition of inh ...... ng human natural killer cells.
@en
P2093
P2860
P1433
P1476
Coordinated acquisition of inh ...... ing human natural killer cells
@en
P2093
Bartosz Grzywacz
Bruce R Blazar
Elaine A Dzierzak
Magdalena Sikora
Michael R Verneris
Nandini Kataria
P2860
P304
P356
10.1182/BLOOD-2006-04-020198
P407
P577
2006-08-10T00:00:00Z